ATI Ch 32 Medications Affecting Labor and Delivery
(Exam 2023 A+)
1. A nurse is teaching a client about terbutaline. Which of the following statements
... [Show More] by
the client indicates understanding of the teaching?
A. "This medication will stop my contractions."
B. "This medication will prevent vaginal bleeding."
C."This medication will promote blood ow to my baby."
D."This medication will increase my prostaglandin production." - 1. A. CORRECT:
Terbutaline blocks beta2‐adrenergic receptors, which causes uterine smooth muscle
relaxation.
B. Terbutaline is used to suppress preterm labor and does not prevent bleeding.
C. Terbutaline causes smooth muscle relaxation and does not promote placental blood
ow.
D. Terbutaline suppresses uterine contractions and does not increase prostaglandin
production.
2. A nurse is caring for a client
who has preeclampsia and is receiving magnesium sulfate IV continuous infusion.
Which of the following ndings should the nurse report to the provider?
A. 2+ deep tendon re exes B. 2+ pedal edema
C. 24 mL/hr urinary output D. Respirations 12/min - 2. A. This is an expected nding and
does not need to be reported to the provider.
B. This is an expected nding and does not need to be reported to the provider.
C. CORRECT: Urine output less than 25 to 30 mL/hr is associated with magnesium
sulfate toxicity and should be reported to the provider.
D. A respiratory rate of 12/min is an expected nding and does not need to be reported to
the provider.
3. A nurse is caring for a client
who has a new prescription for oxytocin to stimulate uterine contractions. Which of the
following interventions should the nurse make? (Select all that apply.)
A. Use an infusion pump for medication administration.
B. Obtain vital signs frequently and with every dosage change.
C. Stop infusion if uterine contractions occur every
4 min and last 45 seconds.
D. Increase medication infusion rate rapidly.
E. monitor fetal heart rate continuously. - 3. A. CORRECT: Oxytocin must be
administered by an infusion pump to ensure precise dosage.
B. CORRECT: Vital signs are monitored to assess for hypertension, an adverse effect
of oxytocin.
C. Infusion should not be stopped because therapeutic effect has not been achieved.
D. Oxytocin rate is increased gradually to prevent hypertonic uterine contractions.
E. CORRECT: Continuous FhR monitoring is required to assess for fetal distress.
CONTINUES... [Show Less]